Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5.91 CAD | 0.00% | +2.07% | +13.87% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.87% | 437M | |
+12.55% | 9.3B | |
-13.75% | 5.01B | |
+41.51% | 4.47B | |
+4.51% | 3.96B | |
+21.10% | 2.44B | |
-15.23% | 2.41B | |
-25.12% | 2.23B | |
+19.51% | 2.02B | |
+5.74% | 1.69B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- National Bank Downgrades Knight Therapeutics to Sector Perform, Cuts Price Target to $6, on "Soft" Outlook